Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model
暂无分享,去创建一个
[1] A. Valleron,et al. Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe , 1999, Journal of viral hepatitis.
[2] M. Kojiro,et al. Long‐term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: Morphometric analysis of repeated biopsies , 1997, Hepatology.
[3] P. Bedossa,et al. Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .
[4] P. Bedossa,et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.
[5] R H Jones,et al. Multi-state models and diabetic retinopathy. , 1995, Statistics in medicine.
[6] A. Valleron,et al. Modeling the hepatitis C virus epidemic in france , 1999, Hepatology.
[7] A. Valleron,et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. , 1995, American journal of epidemiology.
[8] I M Longini,et al. The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach. , 1991, Journal of acquired immune deficiency syndromes.
[9] Y. Yazdanpanah,et al. Risk of hepatitis C virus transmission to surgeons and nurses from infected patients: model-based estimates in France. , 1999, Journal of hepatology.
[10] William H. Press,et al. Numerical recipes in C , 2002 .
[11] F. Carnot,et al. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. , 1998, Journal of hepatology.
[12] C. Rouzioux,et al. Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: bayesian estimation using a mixture. , 1999, Statistics in medicine.
[13] M. Vidaud,et al. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. , 1999, Gastroenterology.